Gynecologic Cancer
Expert Commentary
Is the HPV test effective as the primary screen for cervical cancer?
YES. In a large, randomized trial from Finland, the HPV test functioned effectively as the primary screen for cervical cancer and was more...
Clinical Review
UPDATE: OVARIAN CANCER
Recent studies shed light on early detection of ovarian cancer—but it’s not a green light for routine screening.
From the Editor
In women who have a pelvic mass: Have you tried this new ovarian Ca biomarker?
You should: It’s been 25 years since a test for ovarian cancer was introduced to assist us
Expert Commentary
Do certain SSRIs reduce the benefits of tamoxifen in breast cancer survivors?
YES. This population-based cohort study found an increased risk of death from breast cancer among women who used tamoxifen and paroxetine (Paxil)...
Expert Commentary
Is new-onset breast tenderness after the start of hormone therapy a sign of elevated cancer risk?
Yes.
From the Editor
Access to screening mammography: Priceless
One breast cancer death of a 40-year-old woman prevented by a mammogram spreads ripples of benefit beyond her life—to her family and across the...
Clinical Review
Confused about mammography guidelines? 7 questions answered
Breast cancer screening recommendations issued by the US Preventive Services Task Force succeeded—in clouding what’s best, for whom. But the air...
News for Your Practice
Women given a diagnosis of CIN face an elevated risk of recurrence
The likelihood of recurrence depends on the grade of CIN, the treatment used, and the woman’s age.
Clinical Review
We’re on the way to ending cervical cancer
3 practical advances bring a “new world” into sight